LPL Financial’s Chembio diagnostics, Inc. CEMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-20,885
Closed -$62K 4502
2021
Q2
$62K Sell
20,885
-4,206
-17% -$14.7K ﹤0.01% 4118
2021
Q1
$88K Sell
25,091
-2,917
-10% -$16.2K ﹤0.01% 3943
2020
Q4
$133K Buy
28,008
+500
+2% +$2.58K ﹤0.01% 3634
2020
Q3
$134K Hold
27,508
﹤0.01% 3316
2020
Q2
$89K Sell
27,508
-15,329
-36% -$146K ﹤0.01% 3306
2020
Q1
$219K Buy
42,837
+500
+1% +$2.02K ﹤0.01% 2745
2019
Q4
$193K Buy
42,337
+3,700
+10% +$18K ﹤0.01% 3111
2019
Q3
$236K Buy
38,637
+3,300
+9% +$19.7K ﹤0.01% 2872
2019
Q2
$215K Buy
+35,337
New +$238K ﹤0.01% 2972

Other funds holding CEMI

LPL Financial's CEMI Position: Q3 2021 in Review

LPL Financial sold out of Chembio diagnostics, Inc. (CEMI) in Q3 2021, closing a stake of 20,885 shares — an estimated $62K sold.

LPL Financial first reported a position in CEMI in Q2 2019 and held it in 9 quarters. The position peaked at $236K in Q3 2019. 47 funds tracked by Wall St. Rank hold CEMI as of Q3 2021.

  • LPL Financial reported no remaining Chembio diagnostics, Inc. position as of Q3 2021 after selling out during the quarter.
  • LPL Financial sold 20,885 Chembio diagnostics, Inc. shares in Q3 2021, an estimated $62K.
  • LPL Financial first reported a position in Chembio diagnostics, Inc. in Q2 2019 and held it in 9 quarters.
  • LPL Financial's Chembio diagnostics, Inc. position peaked at $236K in Q3 2019.
  • 47 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q3 2021.

Based on LPL Financial's 13F filing for Q3 2021, filed 15 Nov 2021.